VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

178 hedge funds and large institutions have $1.75B invested in Viridian Therapeutics in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 79 increasing their positions, 42 reducing their positions, and 24 closing their positions.

Holders
178
Holders Change
+13
Holders Change %
+7.88%
% of All Funds
2.37%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
42
Increased
79
Reduced
42
Closed
24
Calls
$9.76M
Puts
$20.4M
Net Calls
-$10.6M
Net Calls Change
-$11.6M

Top Buyers

1
Loomis, Sayles & Company
1
Loomis, Sayles & Company
Massachusetts
$26.8M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$25.4M
3
State Street
3
State Street
Massachusetts
$67.5M
4
BlackRock
4
BlackRock
New York
$110M
5
KCM
5
Kynam Capital Management
New Jersey
$63.8M

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
PA
2
Perceptive Advisors
New York
$28.5M
3
PBA
3
Paradigm Biocapital Advisors
New York
$34.9M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
VC
5
Vivo Capital
California
$18.8M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$228M 11,881,912 +698,434 +6%
BlackRock
2
BlackRock
New York
$110M 5,758,577 +954,571 +20%
Vanguard Group
3
Vanguard Group
Pennsylvania
$88.1M 4,595,049 +174,952 +4%
DTC
4
Deep Track Capital
Connecticut
$86.7M 4,522,741 +771,796 +21%
VA
5
VR Adviser
New York
$74.4M 3,882,709 – –
State Street
6
State Street
Massachusetts
$67.5M 3,522,566 +1,142,792 +48%
FFM
7
Fairmount Funds Management
Pennsylvania
$66.1M 3,445,813 – –
KCM
8
Kynam Capital Management
New Jersey
$63.8M 3,326,262 +814,967 +32%
TCM
9
Tang Capital Management
California
$47.8M 2,492,925 +250,000 +11%
CC
10
Commodore Capital
New York
$46M 2,400,000 -150,124 -6%
AllianceBernstein
11
AllianceBernstein
Tennessee
$43.8M 2,286,994 +84,255 +4%
NHAS
12
Novo Holdings A/S
Denmark
$43.1M 2,250,000 -135,000 -6%
MC
13
Maverick Capital
Texas
$39.4M 2,053,906 +56,753 +3%
DCM
14
Driehaus Capital Management
Illinois
$36M 1,875,876 -115,614 -6%
PBA
15
Paradigm Biocapital Advisors
New York
$34.9M 1,820,079 -1,075,610 -37%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$32M 1,670,000 +465,000 +39%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$31.8M 1,658,980 +165,669 +11%
PA
18
Perceptive Advisors
New York
$28.5M 1,486,508 -1,326,157 -47%
Loomis, Sayles & Company
19
Loomis, Sayles & Company
Massachusetts
$26.8M 1,400,381 +1,400,381 New
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$25.4M 1,326,811 +1,281,799 +2,848%
Pictet Asset Management
21
Pictet Asset Management
Switzerland
$23.9M 1,248,721 +223,384 +22%
PHP
22
Parkman Healthcare Partners
Connecticut
$20.8M 1,087,634 +662,634 +156%
VC
23
Vivo Capital
California
$18.8M 982,576 -695,631 -41%
Goldman Sachs
24
Goldman Sachs
New York
$17.6M 920,094 +180,841 +24%
OCA
25
Octagon Capital Advisors
New York
$16.7M 870,000 – –
1
2 3 4 5